Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-23

Clinical Trial Update: Neuropeptide Y Regulates Neurogenic Pulp Inflammation [NA]

View source ↗

Summary

Clinical trial investigating Neuropeptide Y as a regulator of neurogenic inflammation in dental pulp tissue has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neuropeptide Y (neuropeptide Y)

Snippet

Sponsor: Institucion Universitaria Colegios de Colombia | Conditions: Neurogenic Inflammation, Dental Pulp Disease | NA | Status: COMPLETED